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There is widespread potential for human exposure to disinfection byproducts (DBPs) in drinking
water because everyone drinks, bathes, cooks, and cleans with water. The need for clean and
safe water led the U.S. Congress to pass the Safe Drinking Water Act more than 20 years ago in
1974. In 1976, chloroform, a trihalomethane (THM) and a principal DBP, was shown to be
carcinogenic in rodents. This prompted the U.S. Environmental Protection Agency (U.S. EPA) in
1979 to develop a drinking water rule that would provide guidance on the levels of THMs allowed
in drinking water. Further concern was raised by epidemiology studies suggesting a weak
association between the consumption of chlorinated drinking water and the occurrence of
bladder, colon, and rectal cancer. In 1992 the U.S. EPA initiated a negotiated rulemaking to
evaluate the need for additional controls for microbial pathogens and DBPs. The goal was to
develop an approach that would reduce the level of exposure from disinfectants and DBPs
without undermining the control of microbial pathogens. The product of these deliberations was a
proposed stage 1 DBP rule. It was agreed that additional information was necessary on how to
optimize the use ofdisinfectants while maintaining control of pathogens before further controls to
reduce exposure beyond stage 1 were warranted. In response to this need, the U.S. EPA
developed a 5-year research plan to support the development of the longer term rules to control
microbial pathogens and DBPs. A considerable body of toxicologic data has been developed on
DBPs that occur in the drinking water, but the main emphasis has been on THMs. Given the
complexity of the problem and the need for additional data to support the drinking water DBP
rules, the U.S. EPA, the National Institute of Environmental Health Sciences, and the U.S. Army
are working together to develop a comprehensive biologic and mechanistic DBP database.
Selected DBPs will be tested using 2-year toxicity and carcinogenicity studies in standard rodent
models; transgenic mouse models and small fish models; in vitro mechanistic and toxicokinetic
studies; and reproductive, immunotoxicity, and developmental studies. The goal is to create a
toxicity database that reflects a wide range of DBPs resulting from different disinfection practices.
This paper describes the approach developed by these agencies to provide the information
needed to make scientifically based regulatory decisions. - Environ Health Perspect 107(Suppl 1):
207-217 (1999). httpz//ehpnetl.niehs.nih.gov/docs/1999,Supp/-11207-217boonarnlabstracthtnl
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The availability ofsafe drinking water is a
substantive health concern. The introduc-
tion ofwater chlorination as a standard
treatment technique caused a large drop
in mortality from infectious disease (1)
and is considered one ofthe major public
health advances in this century. In 1976,
the U.S. National Cancer Institute pub-
lished results showing that chloroform,
one ofthe trihalomethanes (THMs) that
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occurs as a byproduct ofdrinking water
disinfection, was carcinogenic in rodents
(2). Since that time there has been a con-
cern that disinfection ofwater, while pro-
viding protection against microbial risks,
could also pose chemically induced cancer
risks for humans (3). We now know that
other THMs [e.g., bromodichloromethane
(4), chlorodibromomethane (5), and bro-
moform (6)] and other disinfection
byproducts (DBPs), such as dichloroacetic
acid (DCA), are carcinogenic in rodent
bioassays (7,8). Furthermore, several epi-
demiology studies have suggested a weak
association (odds ratios of generally less
than 2) between drinking chlorinated
water and the occurrence ofbladder, rec-
tal, and colon cancer (9-14). In,addition,
disinfection alternatives to chlorine, such
as ozonation, produce byproducts (e.g.,
bromate) that are carcinogenic to rodents
(15,16). Recently, consumption ofdrink-
ing water with high THM levels has been
associated with adverse reproductive out-
comes (17-20). Thus, one of the most
complex issues facing water utilities and
the U.S. Environmental Protection
Agency (U.S. EPA) is how to minimize
the potential DBP health effects yet main-
tain effective control of waterborne
microbial pathogens.
In July 1994 the U.S. EPA proposed
the stage 1 DBP rule (21) in conjunction
with the Interim Enhanced Surface Water
Treatment Rule (IESWTR) (21). The
rules stemmed from a regulatory negotia-
tion process thatbegan in November 1992.
Because ofthe lack ofdata, the negotiators
agreed that there should be a 2-stage DBP
rule and the Enhanced Surface Water
Treatment Rule (21). The stage 1 DBP
rule would be proposed, promulgated, and
implemented concurrently with the
IESWTR to ensure that microbial risk did
not increase as the stage 1 DBP rule was
implemented. The stage 2 DBP rule would
follow after additional information was
obtained on health risk, occurrence, treat-
ment technologies, and analytical methods
to better understand the risk-risk tradeoffs
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between microbial pathogens and those
from DBPs.
The proposed stage 1 DBP rule
included maximum contaminant levels of
80 pg/liter for total THMs, 60 pg/liter for
five haloacetic acids (HAAs), 10 pg/liter for
bromate, and 1 pg/liter for chlorite along
with the best available technologies to con-
trol for these DBPs (21). For the stage 2
DBP rule, the negotiators agreed that the
U.S. EPA would collect data on the para-
meters that influence DBP formation and
the occurrence ofDBPs in drinking water
through the information collection rule.
Based on this information and on new data
generated through research, the U.S. EPA
would develop a stage 2 DBP rule (21).
The Safe Drinking Water Act (SDWA)
(22) was reauthorized in 1996 (23) and
established new regulatory deadlines of
November 1998 for the final stage 1 DBP
rule and May 2002 for the final stage 2
DBP rule.
Animal toxicity studies have been one
ofthe key sources ofdata for policy makers
in setting DBP standards. These animal
toxicity studies have generally focused on
single chemical byproducts at high concen-
trations. These studies have been useful in
identifying potential human reproductive
and carcinogenic risks for several byprod-
ucts; however, human exposures are to
mixtures ofDBPs. Tables 1 and 2 illustrate
several ofthe DBPs that occur from differ-
ent treatment processes. Most health and
occurrence information is on chlorination
byproducts because this has been the pre-
dominant water disinfection method in the
United States. However, water utilities are
considering a shift to alternative disinfec-
tants. Thus, there is a need to better under-
stand the relative risks from DBPs that
occur from other disinfection processes as
well as a need for information on DBP
mixtures. In addition, information on
dose-response relationships and data on
DBPs at concentration levels approaching
human exposures will be important for
making policy decisions. Currently much
ofthose data are lacking.
Given the complexity ofthe issues, an
integrative and multidisciplinary approach
is necessary for developing information
needed to develop future DBP rules. It is
also critical to have an understanding of
the occurrence, human exposure, and ana-
lytical techniques, as well as the toxicity of
the DBPs. The purpose ofthis paper is to
briefly review the existing cancer data on
DBPs and outline a collaborative approach
for cancer hazard assessment for the many
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Table 1.Halogenated byproductsformedbychlorination.a
Oxidation byproducts
THMs
Chloroform
Bromodichloromethane
Chlorodibromomethane
Bromoform
HAAs
Dichloroacetic acid
Trichloroacetic acid
Bromochloroacetic acid
Monochloroacetic acid
Dibromoacetic acid
Monobromoacetic acid
Tribromoacetic acid
Bromodichloroacetic acid
Chlorodibromoacetic acid
HANs
Dichloroacetonitrile
Bromoacetonitrile
Bromochloroacetonitrile
Dibromoacetonitrile
Trichloroacetonitrile
Tribromoacetonitrile
Haloketones
1,1,1-Trichloropropanone
1,1-Dichloropropanone
1,3-Dichloropropanone
Others
Chlorate
Chloral hydrate
Chloropicrin
MX
Cyanogen chloride
Cyanogen bromide
Halonitriles
Concentrations,bpg/liter
Median Maximum
25
9.5
1.6
<0.2
15
11
3.2
1.3
<0.5
<0.5
2.1
0.7
0.6
<0.5
<0.02
1.0
0.4
161
2.1
0.4
0.005
0.62
0.4
240
90
36
7.1
74
85
49
5.8
7.4
1.7
10
4.6
1.1
9.4
0.02
8.3
2.5
9180
25
3.7
0.067
3.7
Reference
ILSI(25) ILSI(25)
I[SI(25)
ILSI(25)
ILSI(25)
ILSI(25)
ILSI(25)
ILSI(25)
ILSI(25) ILSI(25)
ILSI(25) ILSI (25)
Cumming andJolley(59)
Cumming andJoIley(59)
Cumming andJolley(59)
ILSI(25)
ILSI(25)
ILSI(25)
ILSI(25)
ILSI(25)
Bull(7)
Cumming andJoIley(59)
Richardson(49)
Abbreviations: HAAs, haloacetic acids; HANs, haloacetonitriles; ILSI, International Life Sciences Institute; MX, 3-
chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. aStudies have primarily focused on surface water systems where high DBPs would be expected. bMedian and maximum concentrations varywidelydepending on the chemi-
cal/time/source ofsampling.
Table2 Principal byproductsformed byozonation, chlorine dioxide, and chloramination.
Range of
Oxidation byproducts concentrations, pg/liter Reference
Principal productsformed by use ofozonation
Aldehydes
Formaldehyde 1-50 Reckhowand Singer(94) Acetaldehyde 1-50 Reckhowand Singer(94) Glyoxal ND-15 Ferguson etal.(95) Dimethyl glyoxal 0.005-3 Richardson(49) Methylglyoxal ND-8 Richardson(49) Benzaldehyde 0.005-3 Richardson(49) Brominated byproducts
Bromate 1-50 Reckhowand Singer(94) Bromoform 1-50 Reckhowand Singer(94) Brominated acetic acids 1-50 Reckhowand Singer(94) Bromopicrin 1-50 Reckhowand Singer(94) Principal products formed by use ofchlorine dioxide
Chlorite 0.01-5.36 U.S. EPA(96) Chlorate 0.01-4.42 U.S. EPA(96) Plus similaroxidation byproducts as ozonation
Principal productsformedbychloramination
Similar to chlorination but lowerTHMs,
lowercyanogen bromide
Enhanced levels ofcyanogen chloride
Enhanced levels oflargerhydrophilic organic
halides notfurtherdefined
ND, notdetectable.
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chemicals that appear in combinations in
the U.S. drinking water. It is hoped that
this paperwill stimulate discussion and sug-
gestions on the proposed approach. Because
this paper does not provide an extensive
discussion on the health effects data, the
reader may wish to refer to reviews by the
International Agency for Research on
Cancer (24), the International Life Sciences
Institute (25), Bove et al. (26), and Reifet
al. (27). DBPs may pose other health risks
(e.g., reproductive and developmental,
immunotoxicity, neurotoxicity).
Animal Cancer Bioassays
Byproducs fromClorinaton
Trihalomethanes, which generally occur
in the greatest concentrations, were the
first family oforganic compounds identi-
fied as byproducts ofchlorination (28).
Of the four THMs, chloroform was the
first to be evaluated because it often
occurs in the highest concentration (Table
1). Chloroform was tested in a rodent
bioassay by corn oil gavage and was car-
cinogenic (2). The corn oil gavage route of
administration raised some concern as to
whether these results in rats and mice were
relevant for human exposures. Subsequent
studies with drinkingwater exposure found
renal tumors in rodents consistent with the
corn oil studies but did not find mouse
liver tumors (29). Chloroform is one ofthe
best studied DBPs, and extensive research
has been conducted to understand its car-
cinogenic potential. A convincing body of
evidence has emerged that indicates chloro-
form's carcinogenic activity is secondary to
events associated with induced cell injury
and regenerative cell proliferation (30,31).
Other investigators have questioned these
conclusions (32).
The other three THMs have also been
evaluated for carcinogenicity in rodents by
the corn oil gavage route (Table 3). Chloro-
dibromomethane (CDBM) was not associ-
ated with increased tumors in rats, but a
small increase in liver tumors in female
mice was found (5,33). Bromodichloro-
methane (BDCM) caused a dramatic
increase in colon cancer in male and female
rats (34). When BDCM was evaluated by
the drinking water route, liver tumors were
not found in male mice or male rats. In
both studies a low incidence ofrenal cancer
was seen (35). Tribromomethane (bromo-
form) caused a low incidence of colon
tumors in female rats (6,36).
The HAAs (Table 1) are another family
oforganic chemicals that occur frequently
in drinking water (28). DCA causes liver
tumors in mice and rats (8,37-40). TCA
induces liver tumors in mice but not rats
(41). A recent study also found that DCA
caused testicular toxicity (42). The mech-
anism of DCA and trichloroacetic acid
(TCA) carcinogenicity is not clearly
understood, but DCA and TCA may act
by different mechanisms (43-46). DCA's
mode of carcinogenic activity may be
related to modification ofintracellular sig-
naling pathways (31). The carcinogenic
activity ofTCA may be related to peroxi-
someproliferation (8,44,47).
A variety ofhalogenated acetonitriles
have been found in chlorinated drinking
water (28,48). Concentrations ofhalo-
genated acetonitriles typically range from
0.01 to 3 pg/liter (49) but have been rep-
orted as high as 42 pg/liter in Florida (50).
Carcinogenicity ofthe haloacetonitriles has
not been determined (24). The halogenated
acetonitriles cause DNA strand breaks in
cultured human lymphocytes (51), induce
DNA damage in bacteria (52), and induce
sister chromatid exchanges (53). Dibromo-
acetonitrile is considered weakly mutagenic
in Salmonelkl species (54).
Several chlorinated ketones are
produced during chlorination and may be
detected in drinking water (24). These
chemicals generally occur at concentrations
lower than 5 jig/I and there is little toxicity
information available. Halogenated
phenols may be formed but rarely exceed
0.1 pg/I. There is limited evidence of the
carcinogenicity of chlorophenols for
humans with occupational exposures (55).
Chlorinated furanones have received
attention because one member of this
family, 3-chloro-4-(dichloromethyl)-5-
hydroxy-2(5H)-furanone (MX), accounts
for most of the mutagenicity found in
chlorinated drinking water (24). Recent
Table3. Summary ofmajor NTP/U.S. EPA studies ofdisinfection byproductchemicals.
Research design Positive sites forcarcinogenic effects
D/DBPs Dose Route Colon Kidney Liver Reference
THMs
BDCM Rat50-100 mg/kg Oil MR, FR MR - NTP(4)
Mouse 24, 50 mg/kg female Gavage - - FM
75. 150 mg/kg male Oil - MM
Mouse 0.05-0.5g/liter Gavage - MRb
Mouse 0.07-0.7 g/liter Water -
Chloroform Rat90, 200 mg/kg Oil - MR MM, FM National Cancer Institute(2)
Mouse 138,477 mg/kg Gavage -
Chloroform Rat 19, 160 mg/kg Water - MR - Jorgenson etal.(29)
Mouse 34.263 mg/kg Water -
Bromoform Oil MR, FR - - NTP(6)
Gavage
CDBM Rat40, 80 mg/kg Oil - - _ NTP(33)
Mouse 50, 100 mg/kg Gavage - -
HMs
DCA 0.05-3.5 g/liter Water - - MR, FM Bull etal. (8)
Water - - MM
TCA 0.05-5 g/liter Water - - Negativeb Bull etal.(8)
0.05-4.5g/liter Water - - MM, FM
Disinfectants
Chlorine 70-275 ppm Water - - Negative NTP(97)
Chloramine 50-200 ppm Water - - Negative NTP(97)
Abbreviations: BDCM, bromodichloromethane; CDBM, chlorodibromomethane; FM, female mouse; FR, female rat; MM, male mouse; MR, male rat; TCA, trichloroacetic acid.
&Screening studywith limited number ofanimals and sexspecies combinations.bTested in MRonly.
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Finnish studies have shown that this chem-
ical is a multisite carcinogen in rats (56).
This chemical has not been evaluated in
mice. MX occurs at low levels in some
chlorinated drinking water but is more
potent than other DBPs.
A variety ofother chemicals such as
cyanogen halides and chloral hydrate are
found in chlorinated drinking water.
Chlorate hydrate has been found at levels
up to 25 pg/liter (Table 1), whereas the
cyanogen halides are often at 1 pg/liter or
less. Although several THMs and HAAs
have been evaluated in animal studies and
a few have been studied for their mecha-
nisms oftoxicity, many families ofchlori-
nated byproducts lack complete toxicology
or carcinogenicity data.
Byproduct fromOzonation
Ozone treatment is more effective than
chlorine in killing or inactivating harmful
organisms, particularly Cryptosporidium sp.
(57) but provides no residual disinfection.
Ozone alone does not produce chlorinated
byproducts (58), but iffollowed by chlori-
nation or chloramination, many of the
same byproducts as with chlorination are
found, albeit at lower concentrations.
Ozonation disinfection byproducts
include aldehydes and glyoxals (59). In
addition, ozonation ofwater containing
bromine may produce DBPs such as bro-
moform, dibromoacetic acid, cyanogen
bromide, and bromate (59). Formaldehyde
is also produced, but drinking water and
oral studies offormaldehyde have gener-
ally been negative (60,61). Potassium
bromate, administered via drinking water,
caused renal cancer (15), mesotheliomas,
and thyroid follicular cell tumors (62) in
rats. It is generally accepted that potas-
sium bromate will cause renal cancer in
rats (63). In addition to renal cancer,
thyroid, mesothelial, and intestinal neo-
plasms occur in male rats with bromate
administration (64). A significant increase
of8-hydroxydeoxyguanosine was observed
in DNA following oral administration of
potassium bromate and is thought to be
one ofthe DNA lesions involved in potas-
sium bromate carcinogenesis (64). Several
investigators have studied the role ofoxida-
tive damage in bromate-induced carcino-
genesis and have suggested that the
induced tumors may be due to lipid perox-
idation and subsequent DNA damage
(65-68). There is essentially no long-term
toxicity data on cyanogen bromide.
Sodium bromite was negative in short-term
reproductive studies in rats, but sodium
bromate produced reproductive effects in
male rats at a concentration of 20 ppm in
drinking water.
ProductsfromChlorineDioxide
Chlorine dioxide is an effective drinking
water disinfectant (57). The inorganic
species chlorite and chlorate have been
identified as significant byproducts
(57,69). Chlorine dioxide and its degrada-
tion products cause neurodevelopmental
effects in animals (31). There is essentially
no information on the long-term carcino-
genicity effects ofchlorate. There may be a
need to evaluate chlorate because of its
high occurrence and limited toxicity data-
base. Chlorine dioxide will produce low
levels of organic byproducts as compared
to chlorine disinfection but similar organic
byproducts (e.g., aldehydes, ketones) as
compared to ozonation (69).
Product fromChioramluaton
Chloramination is of interest because
treatment ofwater with chloramine results
in lower concentrations of chlorinated
DBPs than with the use ofchlorine (69).
However, significant amounts ofchlori-
nated organic material can form. Little is
known about these byproducts except that
they are more hydrophilic and larger than
organic halides produced from free chlorine
(69). Chloropicrin, cyanogen chloride, 1,1-
dichloropropanone, and chloramines are
some of the byproducts ofconcern (57).
Chloropicrin did not produce evidence of
carcinogenicity in long-term rodent studies.
Much less is known about the haloketones.
Questionsto Be Answered
To provide scientific data for policy deci-
sions, it is necessary to have toxicity data
on relationships between exposure, internal
dose, and toxicity. Although there are sev-
eral vigorous research programs on DBPs,
this is a complex area with many unan-
swered questions. For example, it is neces-
sary to account for sensitive human
subpopulations and the occurrence of
chemical mixtures with potential interac-
tions, and numerous DBPs have only
begun to be studied. We are initiating a
series ofchronic studies to be followed by
shorter-term mechanistic studies. A sys-
tematic approach also requires evaluating a
series ofhypotheses, answers to which can
contribute to the regulatory process. It is
also important to realize that drinking
water standards are based both on potential
health effects and what is technologically
and economically feasible.
Informational Needs
* Additional information on the compar-
ative toxicity and relative potency of
families of DBPs is needed to assist in
determining whether classes of DBPs
should be regulated as individual
chemicals or as a group.
* Additional information is needed on
the relative potency ofbrominated ver-
sus chlorinated DBP species because
there is some evidence that the bromi-
nated species may be more potent than
the chlorinatedspecies.
* Additional information is needed on the
health effects ofthe major byproducts
from the use ofalternative disinfectants
such as chlorine dioxide and ozone.
* Additional mechanistic information is
necessary to assist in providing better
characterizations and estimates of
potential human risk for DBPs.
* There is a need to understand the toxic-
ity of DBP mixtures and how source-
water variables (natural organic matter
as measured by total organic carbon,
bromide ions, and pH) influence the
toxicity ofDBP mixtures.
* There is a need to evaluate alternate
models, such as transgenic mice and fish
models, that will reduce the time and
costfor evaluating the carcinogenicity of
DBPs and that will provide more sensi-
tive methods for evaluating DBP mix-
tures. This is a critical need given the
regulatory deadlines established in the
1996 SDWAamendments (23).
* There is a need for screening data on
the potential immunotoxicity and neu-
rotoxicity ofDBPs.
Approach
An approach for evaluating the potential
health effects for DBPs (Figure 1) starts
with identifyingthe datadeficiencies for the
most commonly occurring DBPs and filling
these data gaps. The next step is developing
a strategy for prioritizing other DBPs for
further research. The following describes
the primary questions that need to be
answered on the potential toxicity ofDBPs.
The first step in answering the questions
posed previously will be to evaluate
selected DBP chemicals in standard rodent
studies. We have selected chemicals that
represent the important families of DBPs
(Figures 1, 2) and chemicals that represent
the various disinfection processes (Table
4). Not all DBPs will be tested in all assays.
BDCM has been selected as the THM of
interest because ofthe colon cancer found
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Figure 1. Structures of the disinfection byproducts selected for evaluation. The largest family of chemicals is the HAAs. These chemicals are being evaluated in rodent, trans-
genic mouse, frog, and fish models. Understanding comparative toxicity and toxicokinetics will allow extrapolation between models and eventually to humans.
in previous corn oil gavage studies. We feel
that the data on the most prevalent THM,
chloroform, are sufficient (2,3,24,29,55,
70,71). DCA, bromochloroacetic acid, and
bromodichloroacetic acid have been
selected as representative ofthe brominated
HAAs. Both dihalogenated and trihalo-
genated acids were selected because the
degree ofhalogenation appears to affect the
mechanism oftoxicity (7).
Another family ofchemicals found after
chlorination is the haloacetonitriles. There
is essentially no carcinogenicity informa-
tion on this family ofchemicals. Therefore,
dibromoacetonitrile was selected as a rep-
resentative member of this family of
chemicals for long-term rodent studies.
A carcinogenic evaluation of the major
mutagen found in drinking water [3-
chloro-4(dichloromethyl)-5-hydroxy-
2(5H)-furanone (MX); also known as
mutagen X] is also scheduled for evalua-
tion in long-term rodent studies. This is of
special interest because MX has recently
been reported to be carcinogenic in rats
(56). Finally, chlorate was selected as a
nonorganic chemical that may be formed
as a result ofinefficient generation ofchlo-
rine dioxide or from the use ofhypochlo-
rite solution and gaseous chlorine for
disinfection. These eight chemicals (Table
4) will be evaluated using drinking water as
the route of administration and will
include 14- or 21-day studies, 90-day
studies, and 2-year carcinogenicity studies.
There will be an emphasis on including
exposure groups close to human exposures
in all studies. Toxicokinetic studies are
planned for all compounds to include the
parent compound and potentially toxic/
carcinogenic metabolites following expo-
sure to the different concentrations. These
studies will help determine whether the
blood levels and target tissue concentra-
tions are linear with exposure concentra-
tions. This information can also be used
for dose-response modeling. Tissues and
animals will also be made available to U.S.
EPA and other scientists for investigator-
initiated studies. The National Institute of
Environmental Health Sciences (NIEHS)
plans to use small grant awards to support
independent investigators in exploring the
potential mechanisms of toxicity for the
various DBPs under test. This will allow
comparisons between specific cellular and
molecular alterations and the carcinogenic-
ity end points in the chronic studies in the
same animals and tissues.
Cost and time will limit the number of
chemicals that can be evaluated in long-
term rodent models. Therefore, there will
Chemical selection
Figure 2. Chemical selection is a balance of selecting
disinfection byproducts formed by the various methods
of disinfection, selecting from the different families of
DBPs, and looking at degree and type of halogenation.
Underlying the selection process is the level and rate
of occurrence ofthe various DBPs in drinking water.
be an emphasis on selecting short-term
models that can provide comparative toxi-
city for more members of each family
class. Currently, there is great interest in
the use of Tg.AC and p53deftransgenic
mouse models for predicting carcinogenic
risk (72). The National Toxicology
Program (NTP), in collaboration with the
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Table 4. Initial byproducts to be evaluated in toxicity studies
Oxidation byproducts Hats/Mice Transgenic mice Fish Reproductive toxicity
THMs
Chloroform X
Bromodichloromethane X X X X
Chlorodibromomethane X
HAAs
DCA X X
Dibromoacetic acid X X
Bromodichloroacetic acid X
Bromochioroacetic acid X
Dibromochloroacetic acid X
Tribromoacetic acid X
HANs
Bromoacetonitrile X
Dibromoacetonitrile X X
MX(-1) X
Ketones
Hexachloropropanone X
Inorganic chemicals
Bromate X X
Chlorate X X
International ILife Sciences Institute, U.S.
pharmaceutical firms, and the Japanese
government, is evaluating more than 40
chemicals including some DBPs in the
Tg.AC and p53deftransgenic mouse mod-
els. We have selected three DBPs for initial
evaluation in these models (Table 4). In
the Tg.AC mouse these chemicals will be
evaluated both by the skin-painting route
of exposure and by drinking water expo-
sure. Because Tg.AC gene expression is
found in both the skin and the fore~
stomach, there is a possibility for good cor-
relation between the two routes of
exposure and with other target organs such
as liver and kidney. Should this correlation
prove accurate, it would create a model
that could be used to screen and rank
numerous DBPs for relative carcinogenic
potency. It could also provide a useful tool
for evaluating chemical mixtures and may
prove a sensitive indicator of tumor
response at doses lower than those used in
the 2-year bioassays. The Tg.AC model
appears most useful for identifying nonmu-
tagenic carcinogens, whereas the p53deI
transgenic mouse model is considered
more useful for identifying mutagenic car-
cinogens (72). DCA, BDCM, and bro-
nmate will also be evaluated in the p53def
transgenic mouse model. These models
provide results at a fraction of the cost of
long-term studies. Because new data can be
obtained in 6 months, additional data can
be obtained for U.S. EPA stage 2 policy
decisions. Blood samples will be collected
from both transgenic mouse models to
provide some indication of parent com-
pound and metabolite levels following
exposure to the different concentrations of
the DBP. This will allow comparison
between the transgenic and standard models
and may provide an understanding of any
differences seen between models. A poten-
tial advantage of these models is that they
will provide an opportunity for evaluating
more DBPs and for predicting comparative
toxicity of DBPs and other chemical fami-
lies found in the drinking water. These
models also should be useful for setting pri-
orities for further research and may guide
effective treatment and regulatory strategies.
However, the use of transgenic mouse and
small fish models is relatively new and their
utility in health risk assessment remains to
be determined. Because we are testing some
DBPs in more than one model, these data
may be useful in extrapolating across these
newer research models.
Epidemiology studies have suggested
that bladder, rectal, and colon cancer are
potentially associated with drinking
chlorinated water (9,12,73,74). The
brominated THMs also cause colon cancer
in rats (34,64). NIEHS investigators will
evaluate the feasibility of using an animal
model ofcolon cancer for the evaluation of
disinfection byproducts. Humans with
familial adenomatous polyposis carry
mutations on an adenomatosis polyposis
coli (APC) gene that is related to inherited
colon cancer. Transgenic mice with muta-
tions in the murine gene analogous to the
human APCgene have been developed and
have a high rate of colon cancer (7576).
Studying the effects of individual DBPs
and combinations ofDBPs and their inter-
actions with a gene that is known to modify
intestinal neoplasia within a few months
may be a powerful tool for ranking the
comparative toxicity of DBPs and DBP
combinations. Further, if these transgenic
mice are particularly sensitive to low con-
centrations of DBPs, it may be possible to
study DBPs at concentrations similar to
those found in drinking water.
In addition to evaluating interactions
between DBPs and relevant genes in trans-
genic murine models, tumors from the var-
ious models will be analyzed for genetic
alterations in the genes most commonly
associated with human cancer (such as ras
and p53). The evaluation of genetic alter-
ations in rodent tumors may help to pro-
vide a better understanding of molecular
mechanisms underlying chemical carcino-
genesis and consequently it is important
for the accurate extrapolation of the cancei
models to humans.
Small fish models are considered short-
term models that can be used to provide
comparative toxicity information for the
members of each family of chemicals and
chemical mixtures (77-80). Several advan-
tages of the Japanese medaka (Oryzias
latipes), a small fish species, include shorter
time to tumor, less expense than rodent
models, and the ability to use large group
sizes for greater sensitivity to detect a subtle
effect. Small fish models have previously
been used to examine chlorination byprod-
ucts (81,82). The medaka has been used
extensively in carcinogenicity research and
has many of the characteristics of a good
cancer model (78,83). The NTP is cur-
rentlyevaluating three rodent carcinogens in
the medaka (84). The U.S. Army Center
for Environmental Health Research
(USACEHR) is evaluating the use of the
medaka model in assessing water supplies
potentially impacted by Army-related func-
tions. Currently, the USACEHR is collabo-
rating with the NIEHS and the U.S. EPA in
studies to evaluate the efficacy of the
medaka model in providing comparative
toxicity data for four ofthe DBP chemicals.
Both short-term acute toxicity tests and
longer-term (9-month) carcinogenicity
assays are being conducted (Table 4).
Incorporated into these assays are experi-
ments designed to provide information on
the role induced hepatocellular prolifera-
tion may play in any neoplastic response
observed. The U.S. EPA has a large medaka
study in progress to establish low-dose
effects of the chemical N-nitrosodi-
ethylamine, a well-known hepatic carcino-
gen in mammals (85,86) and medaka
(87,88). In addition, the U.S. EPA has also
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initiated THM mixture studies using the
medaka (89). Large numbers ofmedaka can
be exposed at relatively modest cost, thus
allowing evaluation of multiple DBP con-
centrations. As with the transgenic models,
blood or liver samples will be collected from
the medaka in these dose-response studies
to provide preliminary indications ofthe tis-
sue-specific concentrations ofthe DBPs and
the levels ofthe formation ofany metabolic
byproducts. These data should help provide
information for comparison between tissue
DBP or metabolite concentrations and
organ toxicity for fish, transgenic, and stan-
dard rodent models. Ifthere is close consis-
tency between exposure concentrations
across several animal models, lower uncer-
tainty factors could be used in risk assess-
ment, whereas large discrepancies across
species would suggest that larger uncertainty
factors be used.
THMs may cause colon cancer in
humans and bromodichloromethane
causes a high incidence ofcolon cancer in
rats (3,34,36). Loss of function of both
alleles of the APCgene results in colorec-
tal cancer in humans (90). There are
mouse models with the mutated APC
gene, including the ApcMin model (75), a
relatively recent mouse model that devel-
ops a high incidence of colon cancer in
just a few months. These mice develop
multiple tumors in both the small and
large intestine. Thus, there is the potential
for a relevant mouse model that has
genetic alterations similar to those in
humans with colon cancer. Because the
utility of this mouse is not well under-
stood for comparative toxicity studies,
efforts will be made to adapt the model
for DBP studies. One of the first chemi-
cals to be chosen will be BDCM because
it has already been shown to cause colon
cancer in rats and is under study in fish
and other transgenic mouse models. This
model has the potential to increase our
understanding of DBP carcinogenicity at
the gene level.
A series of DBPs were identified by
the U.S. EPA as being ofspecial concern
for reproductive/developmental toxicity.
These DBPs are being tested using the
design method of Harris et al. (91), which
tests the components of reproduction in
parallel (e.g., spermatogenesis, ovulation,
implantation, fetal growth, etc.) in rodents.
Additionally, clinical chemistry, hema-
tology, and cell turnover data are collected
by the NTP reproductive toxicity pro-
gram. These additional data may be useful
to help set doses and identify target organs
for planned carcinogenicity studies. An
amphibian assay is also being used. The
frog embryo teratogenesis assay-Xenopus
(FETAX) is a 96-hr assay that utilizes the
embryos of the South African clawed frog,
Xenopus laevis, to test for the potential ter-
atogenicity ofsingle compounds. The assay
can be used to assess both single com-
pounds and complex mixtures and is
applicable in the weight-of-evidence
approach for establishing water quality cri-
teria, biomonitoring, toxicity screening,
and hazard assessment. The assay has been
used extensively in interlaboratory valida-
tion studies, including the testing of 12
NTP-recommended compounds. The
FETAX model will be used to assess the
developmental toxicity ofDBP compounds
by the NTP reproductive toxicity program
and by the U.S. EPA Office of Water,
which is sponsoring a pilot study with the
USACEHR to evaluate chlorinated drink-
ing water mixtures. A more detailed
summary ofthis work is in preparation.
Ifthe in vivostudies identify biomarkers
of exposure, the epidemiology studies can
be evaluated to provide much better
indications of a potential association
between exposure to DBPs and the occur-
rence of toxicity and cancer (Figure 3).
Biomarkers of exposure may be useful in
identifying a population at risk for toxicity.
To date, epidemiology studies suffer
from the difficulty of establishing sound
exposure measures for people who are
exposed to low concentrations of DBPs
that vary widely over the years. Evaluation
of rodents tested at much higher concen-
trations, if they lead to unique adducts,
may provide some clues for evaluation of
humans with different histories ofdrinking
water exposure. The in vivo studies are an
iterative process and as information is
gained from one study it can be used to
alter or improve other studies. Close col-
laboration is necessary between scientists
who are conducting human epidemiology
studies and those conducting animal
studies so that when new data become
available they can be applied to ongoing
studies or used to design new studies.
Mechanisms to Accomplish
the Studies
The magnitude and complexity of the
problem ofsafe drinking water far exceeds
the expertise and resources of any one
agency. Because the NIEHS has been
responsible for many of the chemical
evaluations in the NTP, the NTP has
developed expertise in the design and
conduct of rodent studies and will
be responsible for contracting the short-
term rodent studies, the 2-year rodent
studies, and the transgenic studies. The
U.S EPA, through the National Health
and Environmental Effects Research
Laboratory (NHEERL), has established a
Source Exposure Internal dose
ri'j Av;
Susceptible
individuals
Pial
Adverse
biological
effect
*toxicity
* cancer
* molecular
mechanisms
Response
Figure 3. Evaluation of disinfection byproducts. The overall evaluation of drinking water for safety is complex,
involving water engineering, distribution, study of occurrence, and animal and molecular studies with a sensitivity
to the populations that may be affected from children to individuals with immune deficiency diseases. It is critical
to evaluate chemicals at or near levels that occur in drinking water. When effects are found at higher concentra-
tions, it will be important to determine what changes are occurring at the molecular levels and whether these
effects are also found at or neardrinking water concentrations.
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research program for DBPs. Many of the
NTP studies will include extra animals for
mechanistic studies to be carried out at the
NHEERL. The NHEERL has an active
program exploring oxidative damage,
DNA adducts, and cell replication follow-
ing exposure to various DBPs. This collab-
orative effort has been used by the NTP
for other chemicals and offers the advan-
tage of having the mechanistic studies
done in the same animal model that pro-
vides the evidence oftoxicity and cancer in
the long-term studies. This helps policy-
makers put the rodent study results in
perspective. The U.S. EPA has also estab-
lished an interagency agreement with the
NIEHS for immunotoxicity, reproductive
toxicity, and neurotoxicity studies. This
will allow an evaluation of noncancer end
points, an area that often receives insuffi-
cient attention in hazard evaluation. The
Department of Defense (DOD) has exper-
tise and years ofexperience with small fish
models and the NIEHS has established an
interagency agreement with DOD for
studies with the medaka and FETAX. It is
anticipated that through the grant process,
the NIEHS will support investigators who
want to contribute scientific information
to the area of safe drinking water. Private
water utilities and the American Water
Works Association Research Foundation
(AWWARF) have engineering, water
chemistry, and analytical techniques that
supplement the expertise found within
government agencies. NIEHS scientists
in collaboration with the U.S. EPA are
soliciting advice and sharing data with
AWWARF. It will be important to include
the private sector in the research planning
and research results because laboratory
results must be translated into practical
public health measures. For example, eval-
uation of DBP mixtures that are unlikely
to ever occur provide little practical
knowledge. Although there will be signifi-
cant costs to providing the data necessary
for the U.S. EPA to develop stage 2 DBP
rules based on sound science, there is also
broad support for safe drinking water
programs across several government agen-
cies. Sharing these resources across agen-
cies plus sharing tissues and study data will
extend and optimize the research from
these funds.
Conclusions
Disinfection of drinking water has
been one of the greatest public health
advances in this century. However, animal
studies have suggested that some DBPs in
drinking water may cause an increased
incidence of cancer and reproductive
effects when tested at high concentrations.
Some epidemiology studies have suggested
that drinking chlorinated drinking water
may be associated with increased inci-
dences ofbladder, rectal, and colon cancer
(9,11, 13,14) and adverse reproductive
effects (17). The U.S. EPA has a mandate
to ensure that disinfection of drinking
water controls pathogens but also that the
disinfection process does not increase
other health risks (21-23). Presently,
there are limited data to make sound sci-
entific judgments on the next generation
of drinking water standards. It is impor-
tant that the DBPs are evaluated in a sys-
tematic manner to provide comparative
toxicity data on both HAAs and THMs to
determine the most effective means of
water disinfection.
Health risk assessment is a rapidly
developing science that is emphasizing our
understanding ofthe mechanisms of toxic-
ity (92). It consists of four components
including hazard identification, dose-
response assessment, exposure assessment,
and risk characterization (93). Hazard
identification has been the focus of many
of the early NTP studies, but both the
NTP and the U.S. EPA recognize that haz-
ard identification is only one step in the
risk assessment process. The U.S. EPA is
initiating a new paradigm of risk assess-
ment with a larger focus on understanding
the mechanism of toxicity for each DBP.
For some of the DBPs, important hazard
identification studies have already been
done, thus providing data that are impor-
tant in designing the present studies. For
many DBPs and for DBP mixtures, how-
ever, a better understanding is needed
between the exposure concentrations in the
drinking water, the concentrations at the
cellular level, and the toxicity produced for
the risk assessment paradigm.
A complicating factor when assessing
risk from DBPs is that they occur in
complex mixtures that vary by location,
disinfection process, distance from the
treatment plant, changing conditions of
the source water, and even weather condi-
tions. We are in the initial phases ofhazard
identification and characterization for
DBPs and limited work has been done on
chemical mixtures. One approach is to
study mixtures with known toxicants and
use hypothesis-driven research to explore
the relationship of toxicity when two or
more chemicals are present. We anticipate
that studies ofDBP mixtures and mixtures
of other contaminants will receive
increased attention in the future.
The standard rodent studies supple-
mented with toxicokinetic data and cou-
pled with information on end points such
as cell proliferation, DNA adducts, DNA
repair alterations, and mutagenic events at
the different cellular concentrations will
provide useful data for policy makers. Our
approach also includes the use of trans-
genic mouse models and small fish mod-
els. These data will be less familiar, with
little precedent for using the data to set
regulatory standards. Evaluating several
DBPs in multiple models and having toxi-
cokinetic data for all sex/species combina-
tions evaluated may be useful for assessing
the utility of alternative test species for
screening and ranking DBPs.
Although much remains to be learned,
the DBP studies to date are already
shaping the research approach for the sec-
ond generation of hazard characterization
and dose-response studies. It is anticipated
that there will be major additions to the
DBP toxicity database in the next several
years. Safe drinking water is a critical
resource that affects everyone. Providing
this safe resource is a complex issue involv-
ing engineers, toxicologists, epidemiolo-
gists, chemists, and policy-makers-
expertise that is not contained within a sin-
gle agency or research group. A coordi-
nated approach with input from a wide
variety of stakeholders and researchers
offers the best chance to continue to
provide safe cost-effective drinking water.
DISCLAIMER. This document has been
reviewed in accordance with NIEHS anid U.S.
EPA policy and approved for publication.
Although this paper has been approved for publi-
cation it does not necessarily reflect the views and
policies ofthe U.S. EPA. Mention oftrade names
or commercial products does not constitute
endorsement or recommendation for use.
The views, opinions, and/or findings con-
tained in this paper are those of the authors and
should not be construed as official Department of
the Army position, policy, or decision unless so
designated by other official documentation.
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